share_log

Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pivotal Partners Ltd(7.2%),Pivotal Life Sciences Holdings Limited(7.2%), etc.

SEC announcement ·  Feb 12 21:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more